  | DENIS, A., Frix, A.-N., NGUYEN DANG, D., Malaise, O., DEFOURNY, C., Lovinfosse, P., Corhay, J.-L., GESTER, F., Louis, R., Ribbens, C., & Guiot, J. (November 2023). La pathologie pulmonaire associée à la polyarthrite rhumatoïde. Revue Médicale de Liège, 78 (11), 641-648.  Peer reviewed |
 | Guiot, J., Henket, M., Ernst, M., Seidel, L., WINANDY, M.-L., DENIS, A., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., Garah, O., Njock, M.-S., CANIVET, P., Meunier, P., Corhay, J.-L., Regnier, C., Malaise, O., Malaise, M., & Louis, R. (09 March 2023). Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis. Frontiers in Medicine, 10. doi:10.3389/fmed.2023.1063012 Peer Reviewed verified by ORBi |
 | DENIS, A., Henket, M., Ernst, M., Maes, N., THYS, M., Regnier, C., Malaise, O., Frix, A.-N., GESTER, F., DESIR, C., Meunier, P., Louis, R., Malaise, M., & Guiot, J. (30 November 2022). Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.1024298 Peer Reviewed verified by ORBi |
 | Frix, A.-N., Heaney, L. G., Dahlén, B., Mihaltan, F., Sergejeva, S., Popović-Grle, S., Sedlak, V., Lehtimäki, L., Bourdin, A., Korn, S., Zervas, E., Csoma, Z., Lúðvíksdóttir, D., Butler, M., Canonica, G. W., Grisle, I., Bieksiene, K., Ten Brinke, A., Kuna, P., ... Louis, R. (October 2022). Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. ERJ Open Research, 8 (4), 00273-2022. doi:10.1183/23120541.00273-2022 Peer Reviewed verified by ORBi |
 | Guiot, J., Maes, N., WINANDY, M.-L., Henket, M., Ernst, B., THYS, M., Frix, A.-N., Morimont, P., Rousseau, A.-F., CANIVET, P., Louis, R., Misset, B., Meunier, P., Charbonnier, J.-P., & Lambermont, B. (29 August 2022). Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.930055 Peer Reviewed verified by ORBi |
 | De Niet, S., Trémège, M., Coffiner, M., Rousseau, A.-F., CALMES, D., Frix, A.-N., GESTER, F., Delvaux, M., DIVE, A.-F., GUGLIELMI, E., Henket, M., Staderoli, A., Maesen, D., Louis, R., Guiot, J., & Cavalier, E. (26 July 2022). Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients, 14 (15), 3048. doi:10.3390/nu14153048 Peer Reviewed verified by ORBi |
 | CANIVET, P., DESIR, C., THYS, M., Henket, M., Frix, A.-N., Ernst, B., Walsh, S., Occhipinti, M., Vos, W., Maes, N., Canivet, J. L., LOUIS, R., MEUNIER, P., & Guiot, J. (28 June 2022). The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave. Diagnostics, 12 (7), 1567. doi:10.3390/diagnostics12071567 Peer Reviewed verified by ORBi |
 | Refaee, T., Salahuddin, Z., Frix, A.-N., Yan, C., Wu, G., Woodruff, H. C., Gietema, H., MEUNIER, P., LOUIS, R., GUIOT, J., & Lambin, P. (23 June 2022). Diagnosis of Idiopathic Pulmonary Fibrosis in High-Resolution Computed Tomography Scans Using a Combination of Handcrafted Radiomics and Deep Learning. Frontiers in Medicine, 9. doi:10.3389/fmed.2022.915243 Peer Reviewed verified by ORBi |
  | LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598 Peer Reviewed verified by ORBi |
 | Schleich, F., Graff, S., Bougard, N., Frix, A.-N., Peerboom, S., Demarche, S., GUISSARD, F., PAULUS, V., Henket, M., CALMES, D., Moermans, C., & Louis, R. (May 2022). L’asthme bronchique en pratique clinique : des phénotypes inflammatoires au traitement personnalisé. Revue Médicale de Liège, 77 (5-6), 289-294. Editorial Reviewed verified by ORBi |
 | GUIOT, J., HENKET, M., Frix, A.-N., GESTER, F., THYS, M., GILTAY, L., DESIR, C., MOERMANS, C., NJOCK, M.-S., MEUNIER, P., CORHAY, J.-L., & LOUIS, R. (11 April 2022). Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ? Respiratory Research, 23 (1), 89. doi:10.1186/s12931-022-02006-9 Peer Reviewed verified by ORBi |
 | Cambier, M., Henket, M., Frix, A.-N., Gofflot, S., THYS, M., Tomasetti, S., Peired, A., Struman, I., Rousseau, A.-F., Misset, B., Darcis, G., Moutschen, M., Louis, R., Njock, M.-S., Cavalier, E., & Guiot, J. (2022). Increased KL-6 levels in moderate to severe COVID-19 infection. PLoS ONE, 17 (11), 0273107. doi:10.1371/journal.pone.0273107 Peer Reviewed verified by ORBi |
 | Guiot, J.* , Vaidyanathan, A.* , DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., Lambin, P., Bottari, F., Tsoutzidis, N., Miraglio, B., Walsh, S., Vos, W., Hustinx, R., Ferreira, M., LOVINFOSSE, P.* , & Leijenaar, R. T. H.*. (2022). A review in radiomics: Making personalized medicine a reality via routine imaging. Medicinal Research Reviews. doi:10.1002/med.21846 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
Denis, A., Henket, M., GESTER, F., THYS, M., Ernst, M., Maes, N., GILTAY, L., Frix, A.-N., Maloir, Q., Meunier, P., DESIR, C., Louis, R., & Guiot, J. (September 2021). Incidence, prevalence and mortality of rheumatoid arthritis-associated interstitial lung disease : a retrospective study [Poster presentation]. ERS International Congress 2021. doi:10.1183/13993003.congress-2021.PA2542 |
 | Frix, A.-N., COUSIN, F., Refaee, T., Bottari, F., Vaidyanathan, A., DESIR, C., Vos, W., Walsh, S., Occhipinti, M., LOVINFOSSE, P., Leijenaar, R. T. H., HUSTINX, R., MEUNIER, P., LOUIS, R., Lambin, P., & GUIOT, J. (25 June 2021). Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians. Journal of Personalized Medicine, 11 (7), 602. doi:10.3390/jpm11070602 Peer Reviewed verified by ORBi |
 | Schoneveld, L., LADANG, A., HENKET, M., Frix, A.-N., Cavalier, E., Guiot, J., MALAISE, O. (Other coll.), & LAMBERMONT, B. (Other coll.). (February 2021). YKL-40 as a new promising prognostic marker of severity in COVID infection. Critical Care, 25 (1), 66. doi:10.1186/s13054-020-03383-7 Peer reviewed |
 | Chatterjee, A., Wu, G., Primakov, S., Oberije, C., Woodruff, H., Kubben, P., Henry, R., Aries, M. J. H., Beudel, M., Noordzij, P. G., Dormans, T., Gritters van den Oever, N. C., van den Bergh, J. P., Wyers, C. E., Simsek, S., Douma, R., Reidinga, A. C., de Kruif, M. D., GUIOT, J., ... Lambin, P. (2021). Can predicting COVID-19 mortality in a European cohort using only demographic and comorbidity data surpass age-based prediction: An externally validated study. PLoS ONE, 16 (4), 0249920. doi:10.1371/journal.pone.0249920 Peer Reviewed verified by ORBi |
 | GUIOT, J., Vaidyanathan, A., DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., THYS, M., HENKET, M., CANIVET, G., Mathieu, S., EFTAXIA, E., Lambin, P., Tsoutzidis, N., Miraglio, B., Walsh, S., Moutschen, M., Louis, R., Meunier, P., Vos, W., ... LOVINFOSSE, P. (2021). Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19. Diagnostics, 11 (1). doi:10.3390/diagnostics11010041 Peer reviewed |
 | Louis, R., CALMES, D., Frix, A.-N., & Schleich, F. (2021). COVID-19 et asthme. Revue Médicale de Liège, 75 (S1), 130-132. Peer reviewed |
 | CALMES, D., Graff, S., MAES, N., Frix, A.-N., THYS, M., BONHOMME, O., Berg, J., DEBRUCHE, M., GESTER, F., HENKET, M., PAULUS, V., DUYSINX, B., HEINEN, V., NGUYEN DANG, D., PAULUS, A., QUAEDVLIEG, V., VAILLANT, F., VAN CAUWENBERGE, H., MALAISE, M., ... SCHLEICH, F. (2021). Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection. Journal of Allergy and Clinical Immunology: In Practice, 9 (1), 160-169. doi:10.1016/j.jaip.2020.09.044 Peer Reviewed verified by ORBi |
 | Frix, A.-N., Schoneveld, L., LADANG, A., HENKET, M., DUYSINX, B., VAILLANT, F., Misset, B., Moutschen, M., Louis, R., Cavalier, E., & Guiot, J. (November 2020). Could KL-6 levels in COVID-19 help to predict lung disease? Respiratory Research, 21 (309). doi:10.1186/s12931-020-01560-4 Peer Reviewed verified by ORBi |
 | Wu, G., Yang, P., Xie, Y., Woodruff, H. C., Rao, X., Guiot, J., Frix, A.-N., Louis, R., Moutschen, M., Li, J., Li, J., Yan, C., Du, D., Zhao, S., Ding, Y., Liu, B., Sun, W., Albarello, F., D'Abramo, A., ... Lambin, P. (2020). Development of a Clinical Decision Support System for Severity Risk Prediction and Triage of COVID-19 Patients at Hospital Admission: an International Multicenter Study. European Respiratory Journal. doi:10.1183/13993003.01104-2020 Peer Reviewed verified by ORBi |
 | Frix, A.-N., Schleich, F., PAULUS, V., GUISSARD, F., HENKET, M., & Louis, R. (2020). Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma. Biochemical Pharmacology, 179. doi:10.1016/j.bcp.2020.113944 Peer Reviewed verified by ORBi |
 | GUIOT, J., HENKET, M., Frix, A.-N., Delvaux, M., DENIS, A., GILTAY, L., THYS, M., GESTER, F., MOUTSCHEN, M., CORHAY, J.-L., LOUIS, R., LAMBERMONT, B. (Other coll.), & MALAISE, O. (Other coll.). (2020). Single-center experience of patients with interstitial lung diseases during the early days of te COVID-19 pandemic. Respiratory Investigation, 58 (6), 437-9. doi:10.1016/j.resinv.2020.08.006 Peer Reviewed verified by ORBi |
 | Schleich, F., Frix, A.-N., Paulus, V., Guissard, F., Sanchez, C., Henket, M., & Louis, R. (2020). Une décennie d’avancées dans l’asthme : l’apport des biothérapies. Revue Médicale de Liège, 75 (5-6), 350-355. Peer reviewed |
 | Frix, A.-N., HEINEN, V., SCHLEICH, F., DUYSINX, B., PAULUS, V., & Louis, R. (2019). Thermoplastie bronchique dans le traitement de l’asthme sévère. Analyse rétrospective de 10 cas traités au CHU de Liège. Revue Médicale de Liège, 74 (2), 74-81. Peer reviewed |